CHPA Commends Sponsors of Designer Anabolic Steroid Control Act

Legislation would increase penalties for ‘rogue’ supplement manufacturers

Washington, D.C. (July 25, 2012)—The Consumer Healthcare Products Association (CHPA) sent a letter of support to U.S. Sens. Sheldon Whitehouse (D-RI) and Orrin Hatch (R-UT), thanking them for sponsoring the Designer Anabolic Steroid Control Act (DASCA), introduced today.  DASCA would add certain chemicals to the list of anabolic steroids and impose harsher penalties for violators who add these chemicals to their products marketed as dietary supplements.

“CHPA commends Sens. Whitehouse and Hatch for their efforts to ensure the safety of dietary supplements,” CHPA President and CEO Scott Melville said.

“Consumers must be able to trust that the information they read on the Supplement Facts label and ingredient list is accurate, that the dietary ingredients are safe, and that the content matches the amount declared on the label. DASCA will safeguard this trust by increasing the penalties for rogue supplement manufacturers that ‘spike’ their products with anabolic steroids and attempt to pass them off as dietary supplements.”

Contact: Jenni Terry, 202.429.9260


CHPA is the 131-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.